Literature DB >> 34722716

Ischemic Preconditioning for Liver Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Lina Jakubauskiene1,2, Matas Jakubauskas1,2, Philipp Stiegler1, Bettina Leber1, Peter Schemmer1, Kestutis Strupas2.   

Abstract

BACKGROUND: In recent decades, liver transplantation (LTx) has increased the survival and quality of life of patients with end-stage organ failure. Unfortunately, LTx is limited due to the shortage of donors. A lot of effort is put into finding new ways to reduce ischemia-reperfusion injury (IRI) in liver grafts to increase the number of suitable organs procured from expanded-criteria donors (ECD). The aim of this study was to systematically review the literature reporting LTx outcomes when using ischemic preconditioning (IPC) or remote ischemic preconditioning (RIPC) to reduce IRI in liver grafts.
METHODS: A literature search was performed in the MEDLINE, Web of Science, and EMBASE databases. The following combination was used: "Liver" OR "Liver Transplantation" AND "Ischemic preconditioning" OR "occlusion" OR "clamping" OR "Pringle." The following outcome data were retrieved: the rates of graft primary nonfunction (PNF), retransplantation, graft loss, and mortality; stay in hospital and the intensive care unit; and postoperative serum liver damage parameters.
RESULTS: The initial search retrieved 4,522 potentially relevant studies. After evaluating 17 full-text articles, a total of 9 randomized controlled trials (RCTs) were included (7 IPC and 2 RIPC studies) in the qualitative synthesis; the meta-analysis was only performed on the data from the IPC studies. RIPC studies had considerable methodological differences. The meta-analysis revealed the beneficial effect of IPC when comparing postoperative aspartate aminotransferase (AST) corresponding to a statistically lower mortality rate in the IPC group (odds ratio [OR] 0.51; 95% confidence interval [CI] 0.27-0.98; p = 0.04).
CONCLUSION: IPC lowers postoperative AST levels and reduces the mortality rate; however, data on the benefits of RIPC are lacking.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Extended criteria donors; Ischemic preconditioning; Liver transplantation; Marginal grafts

Year:  2021        PMID: 34722716      PMCID: PMC8543359          DOI: 10.1159/000516608

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  29 in total

Review 1.  Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review.

Authors:  Waqas Farooqui; Hans Christian Pommergaard; Allan Rasmussen
Journal:  Transplant Rev (Orlando)       Date:  2017-06-15       Impact factor: 3.943

2.  Hypothermic machine preservation reduces molecular markers of ischemia/reperfusion injury in human liver transplantation.

Authors:  S D Henry; E Nachber; J Tulipan; J Stone; C Bae; L Reznik; T Kato; B Samstein; J C Emond; J V Guarrera
Journal:  Am J Transplant       Date:  2012-05-17       Impact factor: 8.086

Review 3.  Improving long-term outcomes after liver transplantation.

Authors:  Michael R Charlton
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

4.  Remote ischaemic preconditioning in orthotopic liver transplantation (RIPCOLT trial): a pilot randomized controlled feasibility study.

Authors:  Francis P Robertson; Rup Goswami; Graham P Wright; Charles Imber; Dinesh Sharma; Massimo Malago; Barry J Fuller; Brian R Davidson
Journal:  HPB (Oxford)       Date:  2017-06-24       Impact factor: 3.647

5.  High serum Aspartate transaminase levels on day 3 postliver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.

Authors:  Francis P Robertson; Paul R Bessell; Rafael Diaz-Nieto; Niclas Thomas; Nancy Rolando; Barry Fuller; Brian R Davidson
Journal:  Transpl Int       Date:  2015-12-29       Impact factor: 3.782

6.  Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.

Authors:  Mauricio Gabrielli; Fabrizio Moisan; Marcela Vidal; Ignacio Duarte; Macarena Jiménez; Guillermo Izquierdo; Pilar Domínguez; Javier Méndez; Alejandro Soza; Carlos Benitez; Rosa Pérez; Marco Arrese; Juan Guerra; Nicolás Jarufe; Jorge Martínez
Journal:  Ann Hepatol       Date:  2012 Nov-Dec       Impact factor: 2.400

7.  Use of severely steatotic grafts in liver transplantation: a matched case-control study.

Authors:  Lucas McCormack; Henrik Petrowsky; Wolfram Jochum; Beat Mullhaupt; Markus Weber; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

Review 8.  Comprehensive Review on Custodiol-N (HTK-N) and its Molecular Side of Action for Organ Preservation.

Authors:  Judith Kahn; Peter Schemmer
Journal:  Curr Pharm Biotechnol       Date:  2017       Impact factor: 2.837

9.  Impact of combined ischemic preconditioning and remote ischemic perconditioning on ischemia-reperfusion injury after liver transplantation.

Authors:  Ding-Yang Li; Wen-Tao Liu; Guang-Yi Wang; Xiao-Ju Shi
Journal:  Sci Rep       Date:  2018-12-19       Impact factor: 4.379

10.  Effect of Remote Ischemic Preconditioning Conducted in Living Liver Donors on Postoperative Liver Function in Donors and Recipients Following Liver Transplantation: A Randomized Clinical Trial.

Authors:  Kyeo-Woon Jung; Jiwon Kang; Hye-Mee Kwon; Young-Jin Moon; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Ann Surg       Date:  2020-04       Impact factor: 12.969

View more
  1 in total

1.  Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation.

Authors:  Elisa Alchera; Bangalore R Chandrashekar; Nausicaa Clemente; Ester Borroni; Renzo Boldorini; Rita Carini
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.